Moderna Plans To Expand COVID-19 Vaccine Production By 50% Including Boosters, Supply Other Countries
Moderna Inc (NASDAQ:MRNA) will be adding two new production lines at the rebuilt former Polaroid plant where it manufactures its COVID-19…
Analyzing Moderna’s Unusual Options Activity
Moderna (NASDAQ:MRNA) shares experienced unusual options activity on Monday. The stock price moved up to $207.09 following the option alert.
Mayo Clinic, nference AI Analysis Find No Real-World Link Between COVID-19 Shots And Clots
A new study from the artificial intelligence (AI)-driven health technology company, nference, and the Mayo Clinic,
Biden Administration Devotes Over $3.2B For Development Of Oral Antiviral Therapies For COVID-19: CNBC
Officials on Thursday announced that the Biden Administration plans to invest more than $3.2 billion in developing antiviral medicines to…
Moderna Publishes Study Titled ‘A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants’ To ClinicalTrials.Gov Site
https://clinicaltrials.gov/ct2/show/NCT04927065
Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up
It was "better late than never" for Novavax, Inc. (NASDAQ: NVAX), as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted an authorization application to Swissmedic for use of its COVID-19
Benzinga’s Bulls And Bears Of The Week: Apple, Amazon, Biogen, Bitcoin, Tesla And More
Benzinga has examined the prospects for many investor favorite stocks over the past week.
The past week's bullish calls included the e-commerce leader, a top biotech and the airlines.
Nvidia And Dollar Tree Lead The Nasdaq In A Mixed Day For The Markets
U.S. indices had another mixed day of trading following worse-than-expected U.S. jobless figures and inflation data released Thursday.